MRI analysis of the experimental brain tumors demonstrated an increased amount of Gadovist in the glioma mass and brain parenchyma subsequent to anti‐EGFL7, anti‐VEGF, or combinational treatment, indicating increased blood vessel leakage upon inhibition of EGFL7 and VEGF (Fig 6I). The gene discussed is EGFL7; the disease is central nervous system cancer.